Imvexxy Side Effects: What to Expect and When to Call Your Doctor

Every medication carries potential side effects, and Imvexxy (estradiol vaginal inserts) is no exception. Because Imvexxy is a local estrogen therapy — meaning it delivers estradiol directly to vaginal tissue — its systemic absorption is very low compared to oral or transdermal HRT. This means many women tolerate it well. But there are still important safety considerations every patient should understand before starting.

About the FDA Boxed Warning on Imvexxy

Imvexxy carries a boxed warning — the FDA's most serious safety label — that applies to all estrogen-alone therapies. This warning reflects risks identified in studies of systemic estrogen, including the Women's Health Initiative (WHI). Key points from the boxed warning:

• Endometrial cancer: Estrogen-alone therapy may increase the risk of endometrial cancer. If you have a uterus and use Imvexxy, talk to your provider about whether adding a progestogen is appropriate. Report any unusual vaginal bleeding immediately.
• Stroke and blood clots: Estrogen-alone therapy has been associated with increased risk of stroke and deep vein thrombosis (DVT). Do not use Imvexxy if you have a history of stroke, MI, DVT, or PE.
• Dementia: Estrogen-alone therapy may increase the risk of probable dementia in women aged 65 and older based on a substudy of the WHI.
• Cardiovascular disease: Imvexxy should not be used to prevent cardiovascular disease or heart attacks.

Important context: The boxed warning is based primarily on studies of systemic estrogen therapy (oral tablets, patches). Because Imvexxy delivers very low-dose estradiol locally with minimal systemic absorption, many clinicians consider the risk profile to be substantially lower than systemic HRT. Discuss your individual risk factors with your provider.

Common Side Effects of Imvexxy

In clinical trials, the most common side effect reported with Imvexxy (occurring in at least 3% of patients and more than placebo) was:

• Headache — the most commonly reported adverse reaction in the pivotal trial

Other commonly reported side effects that may occur with estrogen therapy include:

• Vaginal discharge or spotting
• Breast pain or tenderness
• Nausea
• Vaginal yeast infections
• Abdominal bloating or cramps
• Back pain

Serious Side Effects — Call Your Doctor or Seek Emergency Care

Seek immediate medical attention if you experience any of the following:

• Unusual vaginal bleeding — postmenopausal bleeding must be evaluated to rule out endometrial cancer
• Signs of blood clot: Leg pain, swelling, redness (DVT); sudden shortness of breath, chest pain (PE)
• Signs of stroke: Sudden numbness/weakness on one side, severe headache, vision changes, confusion, difficulty speaking
• Vision changes: Sudden partial or complete vision loss (potential sign of retinal vascular thrombosis)
• Jaundice: Yellowing of skin or eyes (may indicate cholestatic jaundice requiring discontinuation)
• Breast lump or changes: Any new lump or change in breast tissue warrants prompt evaluation
• Severe allergic reaction: Rash, hives, swelling of face/tongue/throat, difficulty breathing

Who Should NOT Use Imvexxy?

Imvexxy is contraindicated in women who have:

• Undiagnosed vaginal bleeding
• Known or suspected estrogen-dependent cancers (e.g., certain breast or uterine cancers)
• Active or history of blood clots (DVT, PE), stroke, or heart attack
• Liver impairment or disease
• Known hypersensitivity to Imvexxy or any of its ingredients
• Protein C, protein S, antithrombin deficiency, or other thrombophilic disorders

How to Minimize Side Effects

The FDA recommends using the lowest effective dose for the shortest duration necessary. Starting at 4 mcg (rather than 10 mcg) and continuing only as long as symptom relief is needed helps minimize exposure. Schedule regular check-ins with your provider to reassess whether continued treatment is appropriate. For more on using Imvexxy correctly, see our guide on what Imvexxy is used for and how to take it.